EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, DRI Healthcare Trust's Enterprise Value is $623.0 Mil.
DRI Healthcare Trust's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $35.9 Mil. Therefore, DRI Healthcare Trust's EV-to-FCF for today is 17.36.
The historical rank and industry rank for DRI Healthcare Trust's EV-to-FCF or its related term are showing as below:
DHTRF'
s EV-to-FCF Range Over the Past 10 Years
Min: -139.59 Med: -2.16 Max: 20.53
Current: 18.07
During the past 3 years, the highest EV-to-FCF of DRI Healthcare Trust was 20.53. The lowest was -139.59. And the median was -2.16.
DHTRF's EV-to-FCF is ranked better than 63.27% of 550
companies
in the Drug Manufacturers industry
Industry Median: 25.795
vs DHTRF: 18.07
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The historical data trend for DRI Healthcare Trust's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of DRI Healthcare Trust's EV-to-FCF
For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DRI Healthcare Trust's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where DRI Healthcare Trust's EV-to-FCF falls into.
DRI Healthcare Trust's current Enterprise Value is $623.0 Mil.
DRI Healthcare Trust's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $35.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
DRI Healthcare Trust's PE Ratio (TTM) for today is calculated as:
DRI Healthcare Trust's share price for today is $8.49.
DRI Healthcare Trust's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.180.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
DRI Healthcare Trust EV-to-FCF Related Terms
Thank you for viewing the detailed overview of DRI Healthcare Trust's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, primarily focused on acquiring royalty assets. Geographically the trust generates major revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DHTRF has been successfully added to your 